KELA_REIMBURSEMENT_202

MESH PheWeb

K11_REIMB_202

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

KELA reimbursements: KELA codes 202

16690

Check pre-conditions, main-only, mode, ICD version None

16690

Check minimum number of events None

16690

Include endpoints None

16690

K11_REIMB_202

Extra metadata

First used in FinnGen datafreeze DF3

Similar endpoints

↥

List of similar endpoints to KELA_REIMBURSEMENT_202 based on the number of shared cases.

Broader endpoints:

Any reimbursement code in KELA

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	16210	10817	5393
Unadjusted prevalence (%)	5.25	6.23	3.99
Mean age at first event (years)	47.11	46.34	48.66

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.01	1.07 [0.84, 1.35]	5.9e-1	941
15 years	0.01	0.81 [0.66, 1.00]	5.1e-2	445
5 years	0.00	0.98 [0.77, 1.24]	8.6e-1	120
1 year	0.00	1.08 [0.69, 1.68]	7.4e-1	23

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: K11_REIMB_202 – KELA_REIMBURSEMENT_202
GWS hits: 31

Survival analyses between endpoints

↥

Plot

before KELA_REIMBURSEMENT_202
after KELA_REIMBURSEMENT_202

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after KELA_REIMBURSEMENT_202

↥